Literature DB >> 1944596

Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.

S Andersson1, D M Berman, E P Jenkins, D W Russell.   

Abstract

The conversion of testosterone into dihydrotestosterone by steroid 5 alpha-reductase is a key reaction in androgen action, and is essential both for the formation of the male phenotype during embryogenesis and for androgen-mediated growth of tissues such as the prostate. Single gene defects that impair this conversion lead to pseudohermaphroditism in which 46X,Y males have male internal urogenital tracts, but female external genitalia. We have described the isolation of a human 5 alpha-reductase complementary DNA from prostate. Subsequent cloning and genetic studies showed that this gene (designated 5 alpha-reductase 1) was normal in patients with 5 alpha-reductase deficiency. We report here the isolation of a second 5 alpha-reductase cDNA by expression cloning and the polymerase chain reaction. The biochemical and pharmacological properties of this cDNA-encoded enzyme (designated 5 alpha-reductase 2) are consistent with it being the major isozyme in genital tissue. A deletion in this gene is present in two related individuals with male pseudohermaphroditism caused by 5 alpha-reductase deficiency. These results verify the existence of at least two 5 alpha-reductases in man and provide insight into a fundamental hormone-mediated event in male sexual differentiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1944596      PMCID: PMC4451825          DOI: 10.1038/354159a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  22 in total

Review 1.  The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein.

Authors:  H H Hobbs; D W Russell; M S Brown; J L Goldstein
Journal:  Annu Rev Genet       Date:  1990       Impact factor: 16.830

Review 2.  A regulatory hierarchy for cell specialization in yeast.

Authors:  I Herskowitz
Journal:  Nature       Date:  1989-12-14       Impact factor: 49.962

3.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.

Authors:  J R Brooks; E M Baptista; C Berman; E A Ham; M Hichens; D B Johnston; R L Primka; G H Rasmusson; G F Reynolds; S M Schmitt; G E Arth
Journal:  Endocrinology       Date:  1981-09       Impact factor: 4.736

5.  Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans.

Authors:  A Vermeulen; V A Giagulli; P De Schepper; A Buntinx; E Stoner
Journal:  Prostate       Date:  1989       Impact factor: 4.104

6.  Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.

Authors:  T Liang; M A Cascieri; A H Cheung; G F Reynolds; G H Rasmusson
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

7.  Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains.

Authors:  M A Lehrman; W J Schneider; T C Südhof; M S Brown; J L Goldstein; D W Russell
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

8.  A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea.

Authors:  J Imperato-McGinley; M Miller; J D Wilson; R E Peterson; C Shackleton; D C Gajdusek
Journal:  Clin Endocrinol (Oxf)       Date:  1991-04       Impact factor: 3.478

9.  A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome.

Authors:  G Laux; M Perricaudet; P J Farrell
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  87 in total

Review 1.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4.

Authors:  Qian Cheng; Christal D Sohl; Francis K Yoshimoto; F Peter Guengerich
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

3.  Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5α-Reductases.

Authors:  Hwei-Ming Peng; Juan Valentín-Goyco; Sang-Choul Im; Bing Han; Jiayan Liu; Jie Qiao; Richard J Auchus
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

4.  Brain steroid contents in the catfish Heteropneustes fossilis: sex and gonad stage-specific changes.

Authors:  R Chaube; S Mishra
Journal:  Fish Physiol Biochem       Date:  2011-10-15       Impact factor: 2.794

Review 5.  "Getting from here to there"--mechanisms and limitations to the activation of the androgen receptor in castration-resistant prostate cancer.

Authors:  Nima Sharifi; Michael J McPhaul; Richard J Auchus
Journal:  J Investig Med       Date:  2010-12       Impact factor: 2.895

6.  Molecular Basis of Steroid Action in the Prostate.

Authors:  Yuan-Shan Zhu
Journal:  Cellscience       Date:  2005-04-28

7.  Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5alpha-reductase inhibitor, in normal subjects treated with single or multiple doses.

Authors:  Tomoe Fujita; Yoshiaki Matsumoto; Toshimi Kimura; Shinichi Yokota; Mika Sawada; Masataka Majima; Yoshio Ohtani; Yuji Kumagai
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

Review 8.  Testosterone and progesterone metabolism in the central nervous system: cellular localization and mechanism of control of the enzymes involved.

Authors:  L Martini; F Celotti; R C Melcangi
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

Review 9.  Androgen synthesis in adrenarche.

Authors:  Walter L Miller
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

10.  Molecular genetics of steroid 5 alpha-reductase 2 deficiency.

Authors:  A E Thigpen; D L Davis; A Milatovich; B B Mendonca; J Imperato-McGinley; J E Griffin; U Francke; J D Wilson; D W Russell
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.